Skip to main content
. 2024 Jul 9;8(16):4410–4413. doi: 10.1182/bloodadvances.2024013182

Table 1.

2- and 6-year OS and DFS

OS (95% CI)
DFS (95% CI)
2-y 6-y 2-y 6-y
Overall 56% (52-61) 42.7% (38.3-47.6) 54% (49-60) 41.9% (36.8-47.6)
NCCN-FR 74% (67-82) 58.5% (50.3-68.2) 61% (52-71) 50.1% (41.4-60.6)
NCCN-IR 58% (50-68) 41.4% (33-51.8) 61% (52-73) 45% (34.6-58.6)
NCCN-IR MRD negative 79% (66-94) 57.8% (39.8-83.8) 61% (47-80) 52.7% (35.9-77.3)
NCCN-IR MRD positive 70% (57-86) 57% (42.9-75.6) 67% (53-83) 46.6% (32.8-66.1)
NCCN-PR 42% (36-50) 34.1% (27.8-41.9) 45% (37-55) 34.8% (27.3-44.4)
IR-No-LAIP 50% (37-67) 32.5% (20.1-52.7) 48% (33-70) 29.1% (16.2-52.3)

95% CI, 95% confidence interval.